Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japanese Pharma Profits Drop 38 Percent Due To Foreign Acquisitions, Yen Appreciation

This article was originally published in PharmAsia News

Executive Summary

TOKYO - Dragged by brisk research and development outlays and business acquisition costs, 14 leading Japanese drug makers reported an aggregate income shrinkage of 38 percent in the half-year business period ended Sept. 30, the Japan Pharmaceutical Manufacturers Association reported Nov. 17
Advertisement

Related Content

Takeda Copes With FDA Delays, Yen Appreciation and Acquisition Drags in 2008
Takeda Copes With FDA Delays, Yen Appreciation and Acquisition Drags in 2008
Japan’s MHLW Steps Up Efforts To Reduce Drug Approval Lag Time
Advertisement
UsernamePublicRestriction

Register

SC067223

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel